GLOBAL GATEWAY

  • About Us
  • IR
  • Message from the President
  • Management Policy
  • IR News & News Releases
  • IR Library
  • Financial Results
  • Presentations
  • Fact Book
  • Investors Guide
  • Corporate Profile
  • Financial Indicators
  • IR Calender
  • Stock Information
  • Stock Performance (TSE)
  • Analyst Coverage
  • Disclaimer
  • FAQ
  • Contact Us
  • IR Sitemap
  • CSR
  • Topcon Group
Investor RelationsHOME
Presentations
Six-Month Results of the FY2009, ending March 2010 Briefing Session
Date : October 30, 2009
Presenter : President Takashi Yokokura
2,645KB
(46pages)
Earnings Recovery Strategies by Each Business Unit
          (Positioning BU)
897KB
(10pages)
          (Eye Care BU)
837KB
(11pages)
          (Finetech BU)
697KB
(6pages)

Summary of the Presentation

1. Financial Results for the first half FY2009
 
  Net Sales 43,338 million yen (YoY -22,388 million yen)
  Operating Income/Loss -1,836 million yen (YoY -4,855 million yen)
  Ordinary Income/Loss -2,364 million yen (YoY -5,366 million yen)
  Net Income/Loss -2,369 million yen (YoY -3,851 million yen)
 
  For the first half FY2009, net sales was 66% of the results in the first half FY2008 due to the impact from strong yen and stagnated economies in Japan, U.S.A and Europe. For the second quarter FY2009, operating income returned to a profit since our strategies such as sales expansion and fixed-cost reduction were gradually showing positive effects. However, these results were not enough to cover the loss of the first quarter FY2009.
 
· In the Positioning Business, net sales were below our original forecast even though sales were increasing towards the end of the first half FY2009 by launching new products and by growing demands in emerging countries. Operating income exceeded our forecast due to the accelerated integration with Sokkia and the implementation of cost reduction strategy. (It returned to a profit for the second quarter)
· In the Eye Care Business, both net sales and operating income were below our original forecast due to delayed recovery of its business environment and slump in the optometric business.
· In the Finetech Business, net sales and operating income were below our original forecast due to the severe environment in semiconductor segment.

2. Financial Forecast for the FY2009
 
  Net Sales 100,000million yen (YoY -12,666 million yen)
  Operating Income/Loss 1,700 million yen (YoY 8,644 million yen)
  Ordinary Income/Loss 500 million yen (YoY 9,826 million yen)
  Net Income/Loss 200 million yen (YoY 10,192 million yen)
 
  We expect modest recovery in North America, Asia and other emerging countries in the second half FY2009 while it is assumed that recession will be prolonged in Japan and Europe and need more time to be completely in recovery. However, we aim to greatly improve operating income by launching new products and lowering the break even point.
 
· In the Positioning Business, we expect the recovery in net sales and profits by following strategies; expanding sales by launching new products, bringing down of the break even point and extracting synergies by accelerating integration with Sokkia.
· In the Eye Care Business, we are planning to increase net sales and profits by launching new OCT models and focusing on IT solution business and the surgical field.
· Finetech Business strives to return to a profit in the second half by remodeling business portfolio through its restructuring program.

3. Progress in Earnings Recovery Strategy (consolidated)
 
  We have successfully achieved to cut 5.1 billion yen in fixed-cost and 0.5 billion yen in sales-cost (total 5.6 billion yen) by the end of the second quarter FY2009 while the original strategy for the FY2009 was to cut 3.5 billion yen in fixed-cost and 1.8 billion yen in sales-cost (total reduction 5.3 billion yen). Thus, we made an upward revision of the cost reduction strategy for the FY2009, and forecast includes 7.7 billion yen reduction in fixed cost and 1.7 billion yen in sales-cost (total 9.4 billion yen).

Q&A

Q. I think it will be very challenging to achieve the Company's forecast. How are you going to accomplish it?
A. We launched highly competitive products in the first half FY2009, and we continue to supply new and brushed up products for the second half FY2009. These products will be growth drivers boosting our revenues and profits.
 
Q. How are the current business inquiries about the new Eye Care's product “3D OCT,” and what is your sales forecast compared with last fiscal year?
A. We estimate its sales volume in the second half of FY2009 will increase by 1.8 times compared with the first half of FY2009. Also, we estimate net sales for the FY2009 will increase more than 1.5 times compared with last fiscal year.
 
Q. It is vague to visualize Finetech's restructuring program. When will it be realized?
A. Some projects such as product development, which we are allowed to make decisions, have been already suspended. Regarding projects with our alliance partners, we are currently having some business negotiations, and our direction should be set within this year. We assume that we can see the outcome from Finetech's restructuring program next year.

-Cautionary Note regarding Forward-Looking Statements-

These materials contain forward-looking statements, including assumptions and projections based on the information available at the time these statements are made. However, please be aware that actual performance may differ from projected figures owing to unexpected changes in the economic environment in which we operate, as well as to market fluctuations.

Get ADOBE READER    (Open in another window)
Adobe Acrobat Reader is needed to view PDF formatted files.
Acrobat Reader is distributed freely by Adobe Systems.